Novel Imaging Markers for Rheumatoid Arthritis

Completed

• Conditions: Rheumatoid Arthritis

• Registration Number: NCT01773681
• Lead Sponsor: University of California, San Francisco

Brief Summary

The purpose of this study is to use magnetic resonance imaging (MRI) and high-resolution peripheral quantitative computed tomography (HR-pQCT) techniques to look at the damage and disease activity progression in the hand and wrist joints of patients with rheumatoid arthritis.

The central hypothesis is that ongoing erosions and cartilage loss in rheumatoid arthritis are due to persistent inflammation, which is poorly detected by clinical examination and markers of systemic inflammation.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-01-16
• Study First Submitted QC: 2013-01-18
• Study First Posted: 2013-01-23
• Study Start: 2013-10
• Primary Completion: 2018-03
• Study Completion: 2018-03
• Status Verified: 2018-11
• Last Update Submitted: 2018-11-29
• Last Update Posted: 2018-11-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To better understand how Cimzia and methotrexate affect the damage and disease activity progression in the hand and wrist of patients with rheumatoid arthritis	up to 2 years

Trial Locations

Locations (1)

UCSF - China Basin Imaging Center; 🇺🇸 San Francisco, California, United States